11
TITLE: An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
AUTHORS: Vassiliki Saloura; Ezra E W Cohen; Lisa F Licitra; Salem Billan; Jose Dinis; Steen Lisby; Thomas Christoph Gauler;
PUBLISHED: 2013, SOURCE: 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 31, ISSUE: 15
INDEXED IN: WOS
Page 2 of 2. Total results: 11.